» Articles » PMID: 31284181

MORC3 Forms Nuclear Condensates Through Phase Separation

Overview
Journal iScience
Publisher Cell Press
Date 2019 Jul 9
PMID 31284181
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Phase separation can produce local structures with specific functionality in the cell, and in the nucleus, this can lead to chromatin reorganization. Microrchidia 3 (MORC3) is a human ATPase that has been implicated in autoimmune disorders and cancer. Here, we show that MORC3 forms phase-separated condensates with liquid-like properties in the cell nucleus. Fluorescence live-cell imaging reveals that the MORC3 condensates are heterogeneous and undergo dynamic morphological changes during the cell cycle. The ATPase activity of MORC3 drives its phase separation in vitro and requires DNA binding and releasing the MORC3 CW domain-dependent autoinhibition through association with histone H3. Our findings suggest a mechanism by which the ATPase function of MORC3 mediates MORC3 nuclear compartmentalization.

Citing Articles

Identification and characterization of a human MORC2 DNA binding region that is required for gene silencing.

Fendler N, Ly J, Welp L, Lu D, Schulte F, Urlaub H Nucleic Acids Res. 2024; 53(4).

PMID: 39739841 PMC: 11879086. DOI: 10.1093/nar/gkae1273.


MORC protein regulates chromatin accessibility and transcriptional repression in the human malaria parasite, .

Chahine Z, Gupta M, Lenz T, Hollin T, Abel S, Banks C Elife. 2024; 12.

PMID: 39636094 PMC: 11620747. DOI: 10.7554/eLife.92499.


A MORC protein complex modulates epigenetic control of gene expression through interaction with heterochromatin.

Singh M, Bonnell V, Tojal Da Silva I, Feijoli Santiago V, Moraes M, Adderley J Elife. 2024; 12.

PMID: 39412522 PMC: 11483127. DOI: 10.7554/eLife.92201.


Liquid-liquid phase separation in innate immunity.

Liu D, Yang J, Cristea I Trends Immunol. 2024; 45(6):454-469.

PMID: 38762334 PMC: 11247960. DOI: 10.1016/j.it.2024.04.009.


MORC3 represses the HCMV major immediate early promoter in myeloid cells in the absence of PML nuclear bodies.

Champion A, Rowland A, Yee L, van den Boomen D, Reeves M, Lehner P J Med Virol. 2023; 95(11):e29227.

PMID: 38009611 PMC: 10952291. DOI: 10.1002/jmv.29227.


References
1.
Dellaire G, Eskiw C, Dehghani H, Ching R, Bazett-Jones D . Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1. J Cell Sci. 2006; 119(Pt 6):1034-42. DOI: 10.1242/jcs.02817. View

2.
Takahashi K, Yoshida N, Murakami N, Kawata K, Ishizaki H, Tanaka-Okamoto M . Dynamic regulation of p53 subnuclear localization and senescence by MORC3. Mol Biol Cell. 2007; 18(5):1701-9. PMC: 1855011. DOI: 10.1091/mbc.e06-08-0747. View

3.
Gunawardena H, Wedderburn L, Chinoy H, Betteridge Z, North J, Ollier W . Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum. 2009; 60(6):1807-14. PMC: 2701555. DOI: 10.1002/art.24547. View

4.
Mimura Y, Takahashi K, Kawata K, Akazawa T, Inoue N . Two-step colocalization of MORC3 with PML nuclear bodies. J Cell Sci. 2010; 123(Pt 12):2014-24. DOI: 10.1242/jcs.063586. View

5.
Li X, Foley E, Molloy K, Li Y, Chait B, Kapoor T . Quantitative chemical proteomics approach to identify post-translational modification-mediated protein-protein interactions. J Am Chem Soc. 2012; 134(4):1982-5. PMC: 3520067. DOI: 10.1021/ja210528v. View